Despite intensifying competition from AMD and Broadcom, Nvidia's relentless innovation and dominant market position present a compelling case for its stock to potentially double in value by 2026, targeting a staggering $9 trillion market cap.
As YouTube TV prepares a direct assault on the sports streaming market, analysts warn that FuboTV's core business model is under unprecedented threat. With subscriber growth stagnating and financial pressures mounting, the company's path to profitability looks increasingly narrow.
DLocal Limited's third-quarter results reveal a payments platform hitting its stride, with total payment volume soaring 59% year-over-year to a record $10.4 billion. Strong performance in Latin America and strategic expansions underpin a compelling growth narrative for the emerging markets fintech.
Simon Property Group reported robust fourth-quarter and full-year 2025 results, highlighted by record funds from operations, $2 billion in strategic acquisitions, and a significant return of capital to shareholders. The retail REIT giant provided optimistic 2026 guidance, banking on a strong development pipeline and resilient tenant demand despite acknowledging tariff-related headwinds.
For the second consecutive year, a Chicago-based financial institution has become the nation's first bank to fail. Regulators shuttered Metropolitan Capital Bank & Trust on Friday, citing unsafe practices and depleted capital. The FDIC swiftly arranged for Detroit's First Independence Bank to assume most deposits and assets, ensuring customer funds remain secure.
Hyperliquid has upgraded its core engine with the HIP-4 protocol, introducing a novel 'Outcomes' contract system designed for prediction markets and structured products, currently in testnet phase.
DaVita Inc. shares soared after the kidney care provider posted robust fourth-quarter results and issued a 2026 profit forecast that significantly exceeded Wall Street expectations, signaling resilience against cost pressures and past operational challenges.
While its metaverse venture stumbles, Meta Platforms' core advertising engine and strategic shift toward artificial intelligence are convincing analysts it remains the top contender for outperformance among tech's elite group by 2026.
The Internal Revenue Service's free online tracker is now active for taxpayers who have filed their 2025 returns, providing daily updates on refund status and estimated deposit dates for 2026.
The U.S. Treasury Department has outlined its borrowing needs for the first half of 2026, projecting $574 billion in net marketable debt for Q1 followed by a significantly lower $109 billion for Q2, amid adjustments to cash flow forecasts and federal cash balances.
As the energy sector leads the market in early 2026, ConocoPhillips and Kinder Morgan emerge as compelling picks for investors seeking reliable, growing dividends backed by strong fundamentals and strategic positioning.
PLS Group (ASX:PLS) receives significant forecast upgrades from analysts, with revenue projections for 2026 raised to AU$1.6b and the company expected to return to profitability this year.
CNBC's Jim Cramer spotlighted Royal Caribbean Cruises Ltd. (RCL) this week, praising its ambitious full-year 2026 forecast as the cruise line capitalizes on robust post-pandemic demand and operational efficiencies.
Despite its status as the world's most valuable company, Nvidia's stock presents a surprising value proposition. With its GPUs powering the AI revolution, analysts see significant runway for growth well into 2026 and beyond.
As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.
IDEXX Laboratories (IDXX) reported robust double-digit growth for Q4 2025, driven by record placements of its premium diagnostic instruments and expanding test utilization. While acknowledging persistent softness in U.S. veterinary visit volumes, the company outlined a confident initial 2026 forecast, banking on its innovation pipeline and the transformative impact of its inVue Dx system.
With the 2025 tax filing season now open, millions of Americans are looking ahead to their 2026 refunds. We break down how to track your payment, expected wait times, and the potential impact of recent legislation on your bottom line.
A volatile January has underscored a stark shift for investors: political shocks emanating from Washington now pose a greater threat to portfolios than traditional economic or earnings concerns, reshaping risk calculus across global markets.
Following a price target adjustment by Leerink Partners, Kura Oncology (KURA) is drawing investor focus to its 2026 clinical milestones and commercial strategy for its newly launched AML drug, ziftomenib.
Twist Bioscience kicks off fiscal 2026 with robust growth, reporting a 17% year-over-year revenue increase to $103.7 million. The company credits its semiconductor-based DNA synthesis platform and surging demand from AI-enabled drug discovery programs as key drivers, while reiterating its path to adjusted EBITDA breakeven within the year.
